2 unchanged sentences
Our common stock trades under the symbol "SGRY" on the Nasdaq Global Select Market.
−Removed: As of February 25, 2020, there were 125 holders of record of our common stock.
+Added: As of March 3, 2021, there were 132 holders of record of our common stock.
The actual number of common stockholders is greater than the number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees.
7 unchanged sentences
Health Care Providers Index.
−Removed: The graph begins on October 1, 2015, the day our shares were initially sold to the public.
−Removed: The comparison assumes $100 was invested in our common stock and in each of the indices on October 1, 2015 and assumes the reinvestment of dividends, if any.
+Added: The graph begins on December 31, 2015, and the comparison assumes $100 was invested in our common stock and in each of the indices on such date and assumes the reinvestment of dividends, if any.
+Added: 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020
Surgery Partners, Inc.
+Added: $ 100.00 $ 77.35 $ 59.05 $ 47.78 $ 76.40 $ 141.58
Nasdaq Composite Index $ 100.00 $ 107.50 $ 137.86 $ 132.51 $ 179.19 $ 257.38
11 unchanged sentences
Total Number of Shares Purchased (1)
−Removed: Average Price Paid per Share
−Removed: Total Number of Shares Purchased as Part of Publicly Announced Programs
−Removed: Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
−Removed: (in thousands, except share and per share amounts)
+Added: Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Programs Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
+Added: (dollars in millions, except per share amounts)
October 1, 2020 to October 31, 2020 — $ — — $ 46.0
1 unchanged sentence
December 1, 2020 to December 31, 2020 17,534 $ 28.98 — $ 46.0
+Added: Total 17,534 $ 28.98 — $ 46.0
(1) Shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards.
Selected Financial Data
−Removed: The table below contains selected consolidated financial and other data that has been derived from our audited consolidated financial statements for each of the years in the five-year period ended December 31, 2019 .
−Removed: The timing of acquisitions and divestitures completed during the years presented affects the comparability of the selected financial data.
−Removed: The following table covers periods both prior to and subsequent to the Transactions.
−Removed: As discussed in the notes to the consolidated financial statements included in this report, in connection with the change of control effected by the Private Sale, we elected to apply "pushdown" accounting.
−Removed: We have presented the information for the year ended December 31, 2017 on a Predecessor period and Successor period combined basis (each as defined in Note 1.
−Removed: "Organization and Summary of Accounting Policies" of our consolidated financial statements) to facilitate meaningful comparisons of selected consolidated financial and other data to the prior year periods.
−Removed: The following selected consolidated financial and other data should be read in conjunction with "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Item 7 and our consolidated financial statements and the related notes included elsewhere in this report.
−Removed: The results presented below are not necessarily indicative of future results (dollars in millions, except per share amounts):
−Removed: Year Ended December 31,
−Removed: Statements of Operations Data:
−Removed: Net income (loss)
−Removed: Net income attributable to non-controlling interests
−Removed: Net (loss) income attributable to Surgery Partners, Inc.
−Removed: Amounts attributable to participating securities (2)
−Removed: Net (loss) income attributable to common stockholders
−Removed: Per common share data:
−Removed: Consolidated Balance Sheets Data:
−Removed: Working capital
−Removed: Long-term debt, less current maturities
−Removed: Redeemable preferred stock
−Removed: Total stockholders’ equity
−Removed: Statements of Cash Flows Data:
−Removed: Net cash provided by operating activities
−Removed: Net cash used in investing activities
−Removed: Net cash (used in) provided by financing activities
−Removed: Adjusted EBITDA (4)
−Removed: Adjusted EBITDA as a % of revenues
−Removed: Number of surgical facilities as of the end of period (5)
−Removed: Number of consolidated surgical facilities included as of the end of period
−Removed: Revenues in 2019 and 2018 reflect changes related to adoption of ASU 2014-09 as discussed in Note 1.
−Removed: "Organization and Summary of Accounting Policies."
−Removed: Includes accrued dividends for the Series A Preferred Stock for the years ended December 31, 2019, 2018 and 2017.
−Removed: Includes a mark to redemption adjustment for the Series A Preferred Stock for the year ended December 31.
−Removed: There were no participating securities during 2016 and 2015.
−Removed: The impact of potentially dilutive securities for the years ended December 31, 2019, 2018, and 2017 was not considered because the effect would be anti-dilutive in each of those periods.
−Removed: "Management’s Discussion and Analysis of Financial Condition and Results of Operations - Certain non-GAAP Metrics" for a table showing the reconciliation of Adjusted EBITDA to income before income taxes.
−Removed: Includes surgical facilities that we manage but in which we have no ownership interest.
−Removed: SURGERY PARTNERS, INC.
−Removed: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
−Removed: AND RESULTS OF OPERATIONS
+Added: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.